Abstract
Shikonin isolated from the roots of the Chinese herb Lithospermum erythrorhizon has been associated with anti-inflammatory properties. We evaluated shikonin's chemotherapeutic potential and investigated its possible mechanism of action in a human cutaneous neoplasm in tissue culture. Shikonin preferentially inhibits the growth of human epidermoid carcinoma cells concentration- and time-dependently compared to SV-40 transfected keratinocytes, demonstrating its anti-proliferative effects against this cancer cell line. Additionally, shikonin decreased phosphorylated levels of EGFR, ERK1/2 and protein tyrosine kinases, while increasing phosphorylated JNK1/2 levels. Overall, shikonin treatment was associated with increased intracellular levels of phosphorylated apoptosis-related proteins, and decreased levels of proteins associated with proliferation in human epidermoid carcinoma cells.
Original language | English |
---|---|
Pages (from-to) | 115-121 |
Number of pages | 7 |
Journal | Cancer Letters |
Volume | 200 |
Issue number | 2 |
DOIs | |
State | Published - 28 Oct 2003 |
Keywords
- Epidermal growth factor receptor
- Human epidermoid carcinoma cells
- Protein tyrosine kinase
- Shikonin
- c-jun N-terminal kinase